221 related articles for article (PubMed ID: 15855638)
1. Spontaneous corneal hem- and lymphangiogenesis in mice with destrin-mutation depend on VEGFR3 signaling.
Cursiefen C; Ikeda S; Nishina PM; Smith RS; Ikeda A; Jackson D; Mo JS; Chen L; Dana MR; Pytowski B; Kruse FE; Streilein JW
Am J Pathol; 2005 May; 166(5):1367-77. PubMed ID: 15855638
[TBL] [Abstract][Full Text] [Related]
2. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment.
Cursiefen C; Chen L; Borges LP; Jackson D; Cao J; Radziejewski C; D'Amore PA; Dana MR; Wiegand SJ; Streilein JW
J Clin Invest; 2004 Apr; 113(7):1040-50. PubMed ID: 15057311
[TBL] [Abstract][Full Text] [Related]
3. Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation.
Bock F; Onderka J; Dietrich T; Bachmann B; Pytowski B; Cursiefen C
Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):115-9. PubMed ID: 17909835
[TBL] [Abstract][Full Text] [Related]
4. Blockade of the VEGF isoforms in inflammatory corneal hemangiogenesis and lymphangiogenesis.
Lipp M; Bucher F; Parthasarathy A; Hos D; Onderka J; Cursiefen C; Bock F
Graefes Arch Clin Exp Ophthalmol; 2014 Jun; 252(6):943-9. PubMed ID: 24728466
[TBL] [Abstract][Full Text] [Related]
5. Netrin-4 Mediates Corneal Hemangiogenesis but Not Lymphangiogenesis in the Mouse-Model of Suture-Induced Neovascularization.
Maier AB; Klein S; Kociok N; Riechardt AI; Gundlach E; Reichhart N; Strauß O; Joussen AM
Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1387-1396. PubMed ID: 28253401
[TBL] [Abstract][Full Text] [Related]
6. Identification of Novel Endogenous Anti(lymph)angiogenic Factors in the Aqueous Humor.
Bock F; Onderka J; Braun G; Schneider AC; Hos D; Bi Y; Bachmann BO; Cursiefen C
Invest Ophthalmol Vis Sci; 2016 Dec; 57(15):6554-6560. PubMed ID: 27918829
[TBL] [Abstract][Full Text] [Related]
7. Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.
Bucher F; Parthasarathy A; Bergua A; Onderka J; Regenfuss B; Cursiefen C; Bock F
Acta Ophthalmol; 2014 Mar; 92(2):143-8. PubMed ID: 22994268
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of Lymphangiogenesis and Hemangiogenesis in Corneal Inflammation by Subconjunctival Prox1 siRNA Injection in Rats.
Rho CR; Choi JS; Seo M; Lee SK; Joo CK
Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5871-9. PubMed ID: 26348636
[TBL] [Abstract][Full Text] [Related]
9. Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.
Cursiefen C; Schlötzer-Schrehardt U; Küchle M; Sorokin L; Breiteneder-Geleff S; Alitalo K; Jackson D
Invest Ophthalmol Vis Sci; 2002 Jul; 43(7):2127-35. PubMed ID: 12091407
[TBL] [Abstract][Full Text] [Related]
10. Intracellular thiol redox status regulates lymphangiogenesis and dictates corneal limbal graft survival.
Fukumoto A; Maruyama K; Walsh T; Kajiya K; Hamuro J; D'Amore PA; Kinoshita S
Invest Ophthalmol Vis Sci; 2010 May; 51(5):2450-8. PubMed ID: 20042658
[TBL] [Abstract][Full Text] [Related]
11. Inflammation-induced lymphangiogenesis in the cornea arises from CD11b-positive macrophages.
Maruyama K; Ii M; Cursiefen C; Jackson DG; Keino H; Tomita M; Van Rooijen N; Takenaka H; D'Amore PA; Stein-Streilein J; Losordo DW; Streilein JW
J Clin Invest; 2005 Sep; 115(9):2363-72. PubMed ID: 16138190
[TBL] [Abstract][Full Text] [Related]
12. Corneal (lymph)angiogenesis--from bedside to bench and back: a tribute to Judah Folkman.
Regenfuss B; Bock F; Parthasarathy A; Cursiefen C
Lymphat Res Biol; 2008; 6(3-4):191-201. PubMed ID: 19093792
[TBL] [Abstract][Full Text] [Related]
13. Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis.
Hos D; Regenfuss B; Bock F; Onderka J; Cursiefen C
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5778-85. PubMed ID: 21666240
[TBL] [Abstract][Full Text] [Related]
14. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation.
Cursiefen C; Maruyama K; Jackson DG; Streilein JW; Kruse FE
Cornea; 2006 May; 25(4):443-7. PubMed ID: 16670483
[TBL] [Abstract][Full Text] [Related]
15. Novel anti(lymph)angiogenic treatment strategies for corneal and ocular surface diseases.
Bock F; Maruyama K; Regenfuss B; Hos D; Steven P; Heindl LM; Cursiefen C
Prog Retin Eye Res; 2013 May; 34():89-124. PubMed ID: 23348581
[TBL] [Abstract][Full Text] [Related]
16. Involvement of corneal lymphangiogenesis in a mouse model of allergic eye disease.
Lee HS; Hos D; Blanco T; Bock F; Reyes NJ; Mathew R; Cursiefen C; Dana R; Saban DR
Invest Ophthalmol Vis Sci; 2015 May; 56(5):3140-8. PubMed ID: 26024097
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of inflammatory lymphangiogenesis by integrin alpha5 blockade.
Dietrich T; Onderka J; Bock F; Kruse FE; Vossmeyer D; Stragies R; Zahn G; Cursiefen C
Am J Pathol; 2007 Jul; 171(1):361-72. PubMed ID: 17591980
[TBL] [Abstract][Full Text] [Related]
18. Soluble vascular endothelial growth factor receptor 3 is essential for corneal alymphaticity.
Singh N; Tiem M; Watkins R; Cho YK; Wang Y; Olsen T; Uehara H; Mamalis C; Luo L; Oakey Z; Ambati BK
Blood; 2013 May; 121(20):4242-9. PubMed ID: 23476047
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
[TBL] [Abstract][Full Text] [Related]
20. Neuropilin-2 contributes to LPS-induced corneal inflammatory lymphangiogenesis.
Tang X; Sun J; Du L; Du H; Wang L; Mai J; Zhang F; Liu P
Exp Eye Res; 2016 Feb; 143():110-9. PubMed ID: 26500194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
